Main Allergies Blocking Artesunate
Artesunate, an antimalarial from the artemisinin class, is contraindicated in patients with known hypersensitivity to artesunate itself or any artemisinin derivatives (e.g., artemether, arteether). This includes immediate allergic reactions like anaphylaxis, urticaria, or severe rash.[1][2]
Reactions to Watch For
Hypersensitivity manifests as skin reactions (itching, hives), respiratory distress, swelling, or shock. Cross-reactivity occurs within the artemisinin family due to shared chemical structures, so allergy to one typically rules out others.[2][3]
Related Contraindications Often Confused with Allergies
- Hypersensitivity to sulfites: Artesunate injections contain sodium metabisulfite, a sulfite preservative that can trigger reactions in sulfite-sensitive individuals (e.g., asthmatics).[1][4]
- No broad cross-allergy with quinine or other antimalarials: Allergies to quinine or chloroquine do not preclude artesunate use, as mechanisms differ.[2]
Testing and Management
Skin testing or graded challenge dosing may confirm allergy before use. Desensitization protocols exist for confirmed cases in life-threatening malaria.[3][5] Always check product labels—IV forms carry higher sulfite risks than oral.
Why Rare but Critical
Artemisinin allergies affect <1% of users, but in severe malaria, untreated allergy risks outweigh benefits only if alternatives like quinine are viable.[2][6]
[1]: FDA Label - Artesunate (IV)
[2]: WHO Guidelines on Antimalarials
[3]: Journal of Allergy and Clinical Immunology - Artemisinin Hypersensitivity
[4]: Drugs.com - Artesunate Prescribing Info
[5]: Clinical Infectious Diseases - Desensitization Case Reports
[6]: CDC Malaria Treatment